124 related articles for article (PubMed ID: 10610568)
1. Cholesterol-lowering drugs may boost bones.
Vogel G
Science; 1999 Dec; 286(5446):1825-6. PubMed ID: 10610568
[No Abstract] [Full Text] [Related]
2. Stimulation of bone formation in vitro and in rodents by statins.
Mundy G; Garrett R; Harris S; Chan J; Chen D; Rossini G; Boyce B; Zhao M; Gutierrez G
Science; 1999 Dec; 286(5446):1946-9. PubMed ID: 10583956
[TBL] [Abstract][Full Text] [Related]
3. Statins and osteoporosis: can these lipid-lowering drugs also bolster bones?
Cruz AC; Gruber BL
Cleve Clin J Med; 2002 Apr; 69(4):277-8, 280-2, 287-8. PubMed ID: 11996199
[TBL] [Abstract][Full Text] [Related]
4. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
Yoneda T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
[No Abstract] [Full Text] [Related]
5. The formation and secretion of cholesteryl esters in rat hepatocytes are reduced by lovastatin and simvastatin.
MartÃnez MJ; Hernández ML; Isusi E; Aspichueta P; Ochoa B
Biochem Soc Trans; 1998 Feb; 26(1):S82. PubMed ID: 10909840
[No Abstract] [Full Text] [Related]
6. [Stimulation of bone formation by statins].
Komatsu Y; Nakao K
Nihon Rinsho; 2004 Feb; 62 Suppl 2():783-8. PubMed ID: 15035227
[No Abstract] [Full Text] [Related]
7. Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.
Shahrezaee M; Oryan A; Bastami F; Hosseinpour S; Shahrezaee MH; Kamali A
Endocrine; 2018 Apr; 60(1):138-150. PubMed ID: 29372484
[TBL] [Abstract][Full Text] [Related]
8. The role of statins as potential targets for bone formation.
Garrett IR; Mundy GR
Arthritis Res; 2002; 4(4):237-40. PubMed ID: 12106493
[TBL] [Abstract][Full Text] [Related]
9. Simvastatin enhances bone formation around titanium implants in rat tibiae.
Ayukawa Y; Ogino Y; Moriyama Y; Atsuta I; Jinno Y; Kihara M; Tsukiyama Y; Koyano K
J Oral Rehabil; 2010 Feb; 37(2):123-30. PubMed ID: 19889034
[TBL] [Abstract][Full Text] [Related]
10. Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells.
Maeda T; Matsunuma A; Kawane T; Horiuchi N
Biochem Biophys Res Commun; 2001 Jan; 280(3):874-7. PubMed ID: 11162604
[TBL] [Abstract][Full Text] [Related]
11. [Development of BMP-related drugs].
Kawate H; Ohnaka K; Takayanagi R
Nihon Rinsho; 2005 Oct; 63 Suppl 10():463-6. PubMed ID: 16279683
[No Abstract] [Full Text] [Related]
12. [Additional effects of statins independent of the cholesterol-lowering as yet not shown to be clinically relevant].
Stalenhoef AF; Stehouwer CD
Ned Tijdschr Geneeskd; 2000 Feb; 144(7):308-10. PubMed ID: 10707739
[TBL] [Abstract][Full Text] [Related]
13. Statin-induced osteogenesis uses in orthodontics: a scientific review.
Wong RW; Rabie AB
World J Orthod; 2006; 7(1):35-40. PubMed ID: 16548304
[TBL] [Abstract][Full Text] [Related]
14. Early healing pattern of statin-induced osteogenesis.
Wong RW; Rabie AB
Br J Oral Maxillofac Surg; 2005 Feb; 43(1):46-50. PubMed ID: 15620774
[TBL] [Abstract][Full Text] [Related]
15. [Statins have other beneficial properties besides their cholesterol lowering effect].
Eriksson M
Lakartidningen; 1998 Aug; 95(35):3670-2. PubMed ID: 9748780
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous administration of lactone form of simvastatin stimulates ectopic osteoinduction by rhBMP-2.
Sugiyama T; Nakagawa T; Sato C; Fujii T; Mine K; Shimizu K; Murata T; Tagawa T
Oral Dis; 2007 Mar; 13(2):228-33. PubMed ID: 17305627
[TBL] [Abstract][Full Text] [Related]
17. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
[TBL] [Abstract][Full Text] [Related]
18. Statins and bone metabolism.
Horiuchi N; Maeda T
Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
[TBL] [Abstract][Full Text] [Related]
19. Lowering of plasma cholesterol levels in animals by lovastatin and simvastatin.
Chao Y; Chen JS; Hunt VM; Kuron GW; Karkas JD; Liou R; Alberts AW
Eur J Clin Pharmacol; 1991; 40 Suppl 1():S11-4. PubMed ID: 2044637
[TBL] [Abstract][Full Text] [Related]
20. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase.
Endres M; Laufs U; Huang Z; Nakamura T; Huang P; Moskowitz MA; Liao JK
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8880-5. PubMed ID: 9671773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
